Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
TEST:
CNSide™ Cerebrospinal Fluid Assay
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Company:
Biocept
Type:
Laboratory Developed Test
Related tests:
‹
Target Selector™ BRAF Mutation Assay
Target Selector™ EGFR Mutation Assay
Target Selector™ NGS Lung Panel
Target Selector™ BRAF Mutation Assay
Target Selector™ EGFR Mutation Assay
Target Selector™ NGS Lung Panel
›
Details
Evidence
News
CNSide™ is a cerebrospinal fluid (CSF) assay designed to better detect and manage treatment of metastatic cancers involving the central nervous system (CNS).
Cancer:
Brain Cancer, CNS Tumor, Melanoma
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login